DrugPatentWatch Database Preview

Litigation for everolimus

« Back to Dashboard

US Court Litigation for everolimus

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,004,973			2014-08-13	2019-03-27	35:271 Patent Infringement	District Court, D. Delaware	None
6,004,973	Novartis Pharmaceuticals Corporation v. West-Ward Pharmaceuticals International-Limited		2014-09-16	2019-03-14	35:271 Patent Infringement	District Court, D. Delaware	None
6,004,973	Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.		2014-10-10	2019-05-01	35:271 Patent Infringement	District Court, D. Delaware	None
6,004,973	Novartis Pharmaceuticals Corporation v. West-Ward Pharmaceuticals International Limited		2015-06-10	2017-12-20	35:271 Patent Infringement	District Court, D. Delaware	None
6,004,973	Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC		2018-12-19		35:271 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for everolimus

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
5,665,772	Par Pharmaceutical, Inc.		2015-10-26	10-26-2015	COTTENS et al	Inter partes review		04-29-2016	SYLVAIN COTTENS
5,665,772	BRECKENRIDGE PHARMACEUTICAL, INC.		2016-05-10	05-10-2016	Novartis AG	Inter partes review			SYLVAIN COTTENS
5,665,772	Par Pharmaceutical, Inc.		2016-05-17	05-17-2016	Novartis AG	Inter partes review		10-27-2016	SYLVAIN COTTENS
5,665,772	Roxane Laboratories, Inc.		2016-05-26	05-26-2016	Novartis AG	Inter partes review			SYLVAIN COTTENS
5,665,772	Breckenridge Pharmaceutical, Inc.		2016-05-26	05-26-2016	Novartis AG	Inter partes review		10-27-2016	SYLVAIN COTTENS